Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124395002 | 12439500 | 2 | F | 20160131 | 20160819 | 20160606 | 20160826 | EXP | BE-BAYER-2016-021360 | BAYER | 0.00 | E | M | Y | 0.00000 | 20160826 | OT | BE | BE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124395002 | 12439500 | 1 | PS | NEXAVAR | SORAFENIB | 1 | Oral | 400 MG, QD | 21923 | 400 | MG | FILM-COATED TABLET | QD | ||||||
| 124395002 | 12439500 | 2 | SS | NEXAVAR | SORAFENIB | 1 | Oral | 800 MG, QD | 21923 | 800 | MG | FILM-COATED TABLET | QD | ||||||
| 124395002 | 12439500 | 3 | C | ASAFLOW | ASPIRIN | 1 | 20 MG, BID | 0 | 20 | MG | BID | ||||||||
| 124395002 | 12439500 | 4 | C | ZOCOR | SIMVASTATIN | 1 | 40 MG, QD | 0 | 40 | MG | QD | ||||||||
| 124395002 | 12439500 | 5 | C | INDERAL | PROPRANOLOL HYDROCHLORIDE | 1 | 20 MG, BID | 0 | 20 | MG | BID | ||||||||
| 124395002 | 12439500 | 6 | C | LOORTAN | 2 | 50 MG, QD | 0 | 50 | MG | QD | |||||||||
| 124395002 | 12439500 | 7 | C | TANAKAN | GINKGO | 1 | UNK | 0 | QD | ||||||||||
| 124395002 | 12439500 | 8 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 40 MG, QD | 0 | 40 | MG | QD | ||||||||
| 124395002 | 12439500 | 9 | C | NOVORAPID | INSULIN ASPART | 1 | 0 | ||||||||||||
| 124395002 | 12439500 | 10 | C | LANTUS | INSULIN GLARGINE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124395002 | 12439500 | 1 | Hepatocellular carcinoma |
| 124395002 | 12439500 | 2 | Hepatocellular carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124395002 | 12439500 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124395002 | 12439500 | Decreased appetite | |
| 124395002 | 12439500 | Diarrhoea | |
| 124395002 | 12439500 | Fatigue | |
| 124395002 | 12439500 | Hypertension | |
| 124395002 | 12439500 | Hypoglycaemia | |
| 124395002 | 12439500 | Hypoglycaemic unconsciousness | |
| 124395002 | 12439500 | Hypotension | |
| 124395002 | 12439500 | Loss of consciousness | |
| 124395002 | 12439500 | Nausea | |
| 124395002 | 12439500 | Pallor | |
| 124395002 | 12439500 | Vomiting | |
| 124395002 | 12439500 | Weight decreased | |
| 124395002 | 12439500 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124395002 | 12439500 | 1 | 20160112 | 0 |